Published by ChinaMNC · Enshi

China’s New Calibration Standard for Urine Meters: What Foreign Medtech Founders Need to Know

China’s market regulator has issued a national metrology technical specification for urine meters, setting three evaluation dimensions and linking manufacturers, hospitals and regulators. Foreign founders in medical devices should understand how this affects product design, hospital use and compliance in China.

China Issues National Calibration Standard for ICU Urine Meters

China’s State Administration for Market Regulation (SAMR) has released a national metrology technical specification for urine meters, according to a report by CCTV News cited by the regulator. The specification, titled Calibration Specification for Urine Meters, is intended to fill a technical gap in the calibration of these devices in China and to strengthen metrology oversight in critical-care settings.

For foreign founders building or selling medical devices in China, the move is a practical signal: products used in intensive care are increasingly subject to detailed metrological requirements that connect manufacturing, hospital use and regulatory supervision. Understanding these requirements early can help avoid redesigns, delays and compliance friction.

Why Urine Meters Are Treated as Critical-Care Equipment

According to the source, urine output is a core indicator for assessing a critically ill patient’s circulation and kidney function. Urine meters are described as core bedside monitoring equipment in intensive care units (ICUs), continuously collecting and recording patient urine data. Doctors rely on this data when judging a patient’s condition and adjusting treatment plans.

The regulator notes that inaccurate measurement can easily lead to misjudgment of a patient’s condition and directly endanger the safety of critically ill patients. That rationale explains why a dedicated national metrology specification has been introduced rather than leaving calibration to general practice.

The Three Evaluation Dimensions

The specification focuses on three metrological performance evaluation dimensions. Foreign founders should read these as design and quality-control checkpoints, not merely laboratory formalities.

1. Alarm Function

The specification requires that devices can promptly trigger audible and visual alarms when urine output is too high, too low, or when intermittent urine output exceeds a preset threshold. The purpose is to help medical staff quickly identify abnormal changes in a patient’s condition.

For product teams, this means alarm logic, thresholds and notification behavior should be designed and documented in a way that can be verified during calibration and inspection.

2. Accuracy of Total Urine Output Indication

The second dimension assesses a device’s measurement performance for cumulative urine volume over a specified period. The aim is to ensure stable and reliable data during long-term continuous monitoring scenarios.

This matters for devices deployed at the bedside for extended periods, where drift or inconsistency could undermine clinical confidence in the data.

3. Accuracy of Intermittent Urine Output Indication

The third dimension assesses measurement performance for cumulative urine volume within intermittent time periods. It is intended to ensure that real-time displayed or output urine data is accurate and traceable, providing solid and credible data support for clinical diagnosis.

Traceability is a key theme here. Foreign founders should expect that documentation, calibration records and data-output behavior may be examined as part of the broader compliance picture.

How the Specification Connects Industry, Hospitals and Regulators

Once implemented, the specification is intended to connect three links: industry, medical institutions and metrology supervision. Each link carries practical implications for companies operating in China.

Industry Side: Product Design and Factory Controls

On the industry side, the specification is meant to guide manufacturers to optimize product design against actual clinical working conditions and to strengthen metrological performance control at the factory. For foreign founders, this suggests that design choices should reflect real ICU workflows and that factory-level quality controls should be able to demonstrate conformity with the specified evaluation dimensions.

• Design review: Check whether alarm behavior and measurement accuracy are defined for realistic clinical scenarios.
• Factory control: Ensure metrological performance is managed before products leave the manufacturing site.
• Documentation: Keep records that can support calibration and inspection discussions.

Use Side: Hospital Responsibilities

On the use side, the specification is intended to guide medical institutions to establish periodic traceability mechanisms for urine meters, to strengthen the primary responsibility of medical units, and to manage routine metrological control of equipment in use.

For foreign companies whose devices are used in Chinese hospitals, this points to a more structured expectation around calibration cycles and ongoing performance management. Founders should consider how their local partners, distributors or service teams will support hospitals in meeting these expectations.

Regulatory Side: Inspection Basis

On the regulatory side, the specification is intended to provide an authoritative technical basis for market regulation departments conducting metrology supervision and inspection of medical equipment. The stated goal is to achieve full-chain metrology supervision of critical-care equipment from production to clinical use.

This full-chain framing is important. It means the specification is not only a laboratory document; it is also a reference for inspections that may touch manufacturers, healthcare providers and the equipment in service.

Practical Takeaways for Foreign Founders

Foreign founders entering China’s medical device market should treat this specification as part of the operating environment rather than a one-off announcement. The following practical points follow directly from the source.

• Map the three dimensions to your product: Review alarm function, total urine output accuracy and intermittent urine output accuracy against your current design and labeling.
• Plan for hospital traceability: Consider how periodic calibration and traceability will be supported after sale.
• Prepare for inspections: Ensure technical files and calibration-related documentation can be produced when regulators or partners request them.
• Align local operations: Coordinate with Chinese registration, quality and service partners so that manufacturing controls and hospital-use requirements are handled consistently.

The specification is a national metrology technical document. It does not, by itself, replace medical device registration requirements, but it adds a layer of metrological expectation that foreign founders should factor into product planning and China operations.

Next Step for Foreign Founders

Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.